• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Email & Password

Not a member? .

Neostrata ® Peels

First in the U.S. in 1988 by founding Dermatologists Drs. Van Scott and Yu, this product has been in Britain since the late 90s.

Glycolic Acid.

to Medium depth peel.

Using a regimen, you`ll see healthier, younger-looking skin.

It visibly diminishes the look of fine lines and wrinkles, smoothes and softens skin, increases hydration and suppleness, and balances irregular skin tones. It can also oily/acne prone skin.

Higher strengths can help to reduce the appearance of and certain problems.

Nesotrata peels can be used on the face, the neck, the chest and the hands and can be used on all types of skin including: fine skin, normal skin or greasy or thick skin.

It can also be used safely and on black and asian skin.

Medical device.

members of the medical only. It should not be used by beauty therapists.

Neostrata 20%: 20% gylcolic acid

35%: 35% acid

Neostrata 50%: 50% glycolic acid

Neostrata 70%: 70% acid - Used for more of sun damaged skin.

There are a number of special creams and lotions available to be used in combination with Neostrata peels.

Pregnant or women.

The Skin System is a glycolic acid peel system that can only be as an in-office procedure by a . It provides controlled and removal of skin cells, skin renewal to the appearance of the skin. You will notice a difference in your skin immediately. The procedure is fast and convenient, taking only about fifteen minutes. And with virtually no recovery time, you can be back to your normal the same day. There is no significant pain or discomfort or need for anaesthesia.

It takes usually 4-6 at three to four week intervals to the desired effect

All body areas appear to well to treatment with glycolic acid; however, the arms, hands, neck and chest all at a slower rate than the face.

Most patients can glycolic peeling without any side effects. The skin is virtually normal in appearance. The fact that the patient underwent a peel in usually to others. Although rare, a patient may mild sloughing, some or scabbing. Some redness is temporary and normal. Any of these side may be covered with make up.

Rarely, if scabs are picked, scarring may occur or areas of hypopigmentation (lighter coloured skin) or (darker coloured skin) may result from a peel.

Your will discuss these potential side in a .

Again, this depends on area and how much is required, and the practitioner doing the treatment, but ranges are in the region of:£60 to £100 per treatment .

1. Van Scott EJ, Yu RJ. Control of keratinization with alpha and related . Arch 1974; 110: .



2. Van Scott EJ, Yu RJ. Modulation of keratinization with alpha hydroxyacids and related . In: Frost, Gomez and Zaias, Eds. Recent in . Proceedings of Symposium on . New York: Publications 1978; .



3. Van Scott EJ, Yu RJ. Substances that modify the stratum corneum by modulating its . In: Frost, P. and Horwitz, S., eds. Principles of Cosmetics for the Dermatologist. St. Louis: C.V. Mosby 1982; 70-74.



4. Van Scott EJ, Yu RJ. Hyperkeratinization, corneocyte and alpha acids. J Am Acad Dermatol 1984; 11: .



5. Van Scott EJ, Yu RJ. Alpha acids. Therapeutic potentials. Canad J Dermatol 1989; 1(5): .



6. Van Scott EJ, Yu RJ. Alpha Hydroxyacids: procedures for use in . Cutis 1989; 43: .



7. Griffin TD, Van Scott EJ. Use of pyruvic acid in the treatment of actinic keratoses: a clinical and histopathologic study. Cutis 1991; 47: .



8. Hunt MJ, R StC. A study of gluconolactone versus benzoyl in the treatment of acne. Australas J Dermatol 1992; 33: .



9. Van Scott EJ, Yu RJ. Alpha hydroxyacids: and therapeutic use. Cosmet 1994; 7(10s):12-20.



10. EF, Uitto J. Connective tissue in skin and the effects of alpha acids. J Dermatol 1995; 3 Suppl A (3):7A-18A.



11. Leyden JJ, Lavker RM, Grove G, Kaidbey K. Alpha acids are more than . J 1995; 3 Suppl A (3):33A-37A.



12. Van Scott EJ, Yu RJ. Actions of alpha on skin . J Geriatr Dermatol 1995; 3 Suppl A(3):19A-24A.



13. Weinkauf R, Murahata R, Green B. The lactic acid sting test in the evaluation of protective provided by . Amer Acad of Derm Poster Exhibit: Washington D.C., February, 1996.



14. Briden ME, MI. Treatment of Rosacea with acid. J Dermatol 1996; 4(SB):17B-21B.



15. Ditre CM, Griffin TD, Murphy GF, Sueki H, Telegan B, WC, Yu RJ, Van Scott EJ. Effects of alpha on skin: a pilot clinical, histologic and ultrastructural study. J Am Acad Dermatol 1996; 34:187-95.



16. Kakita LS, Petratos MA. The use of glycolic acid in Asian and darker skin types. J Geriatr Dermatol 1996; 4(SB):8B-11B.



17. Leyden JJ. Photodamage: the role of UVA and the role of a-hydroxy acids. Yale University / Glaxo Series in 1996; 5-27.



18. Rendon-Pellerano MI, Bernstein EF. The use of acids in the management of xerosis and . J Geriatr Dermatol 1996; 4(SB):12B-16B.



19. MJ, J, Stern R, Smith S, Kollias N, Gillies R, Drake LA. 8% acid and 8% acid creams for the treatment of skin. Arch 1996; 132: .



20. Van Scott EJ, Yu RJ. Bioavailability of alpha-hydroxy acids in formulations. Cosmet Dermatol 1996; 9(6):54-62.



21. Van Scott EJ, Ditre CM, Yu RJ. Alpha hydroxyacids in the treatment of signs of photoaging. Elsevier Science: Clinics in 1996;14: .



22. DM. Alpha hydroxy acids: what we know and what we need to know. Medical & Surgical 1996;3: .



23. Morganti P, Randazzo SD, G, Bruno C. Decreasing the stinging and improving the antiaging activity of AHAs. J. Appl Cosmetol 1996;14:79-91.



24. Green B, Wildnauer R, Milligan D, Grove G. Comparative clinical of three novel polyhydroxy acids using . Amer Acad of Derm Poster Exhibit: San Francisco, March, 1997.



25. Berardesca E, F, GP, Oresajo C, Green B. Alpha hydroxyacids modulate stratum corneum barrier function. British J Dermatol 1997; 137: .



26. Bergfeld W, Tung R, Vidimos A, L, Remzi B, Stanton-Hicks U. the of skin with glycolic acid. J Am Acad Dermatol 1997; 36: .



27. Bernstein EF, CB, J, Ditre CM, Uitto J, Yu RJ, Van Scott EJ. Citric Acid increases viable epidermal & glycosaminoglycan content of skin. Surg 1997; 23:689-94.



28. Van Scott EJ, Newcomer VD. Masters in dermatology. Dermatol World 1997; Suppl.



29. Yu RJ. Skin irritation and AHA formulation. Cosmet Dermatol 1997; 10(6):31.



30. Yu RJ, Van Scott EJ. acid: not a beta-hydroxy acid. Cosmet 1997; 10(9).



31. Bergfeld WF, Remzi BK, Green B, Patel P, Ravas R. An of the gluconolactone skin care . Amer Acad of Derm Poster Exhibit: Orlando, February, 1998.



32. Bond M, Van Scott EJ. New hydroxy acid for ichthyosis and other severe dry skin. Cosmet Dermatol 1998; 11(2):32-33.



33. Ditre CM. Building your practice with glycolic acid peels. Skin & Aging 1998; 48-53.



34. S, Katz HI, R, Green, B. An evaluation of the effect of an alpha hydroxy acid-blend skin cream in the cosmetic improvement of symptoms of to severe xerosis, epidermolytic hyperkeratosis, and ichthyosis. Cutis 1998; 61: .



35. Tucci MG, MM, G, Morganti P, Vellucci E, Talassi O, Solmi R, Ricotti G. AHAs and derivatives. Cosmetics & 1998;113:55-58.



36. Green B, Tseng C, Wildnauer R, Herndon J, Rizer R. Safety and of a ( acid) containing regimen on skin and photodamage following use. Amer Acad of Derm Poster Exhibit: New Orleans, March, 1999.



37. Green BA, RH. Effect of 10%, 20% and 25% (Citric Acid) Formulations on Skin Morphology. Amer Acad of Derm Poster Exhibit: Washington DC, March, 2000.



38. Green BA, Wildnauer RH, Edison BL. Lactobionic acid OmniJuve – Skin Rejuvenation a novel polyhydroxy bionic acid for . Amer Acad of Derm Poster Exhibit: Washington DC, March, 2000.



39. Green BA. Acid. Skin Inc 2000;11:62-65.



40. Green BA, Beer AE, Edison BL. Use of cosmetics to reduce the visibility of topical skin for enhanced of life. Intl Psoriasis Sym Poster Exhibit: San Francisco, June 2001.



41. Grimes P, Edison BL, Green BA, RH. Evaluation of differences in ethnic skin types and response to topical polyhydroxy acid (PHA) use. Amer Acad of Derm Poster Exhibit: Washington DC, March, 2001.



42. Green BA, RH, Hwu RC, Milora DJ, Edison BL. Amphoteric offer unique benefits to alpha (AHA) skin care . Amer Acad of Derm Poster Exhibit: Washington DC, March, 2001.



43. Bernstein EF, Lee J, Brown DB, Yu RJ, Van Scott EJ. Glycolic acid treatment increases type I Collagen mRNA and hyaluronic acid content of human skin. Surg 2001;27(5):1-5.



44. Kraechter HU, McCaulley JA, Edison B, Green B, Milora DJ. complexes: AHAs with reduced and irritation. Cosmetics & Toiletries 2001;116(1):47-52.



45. Bernstein EF. Chemical Peels. In:

Kaminer, Arndt, Dover, Eds. Atlas of Surgery. W.B. 2001; 18: .



46. Green, B.A., Edison, B.L., Wildnauer, RH, Sigler, M.L. Lactobionic acid and gluconolactone: PHAs for photoaged skin. Cosmetic Dermatology Sep. 2001; 24-28.



47. Bernstein, E.F., Green, B.A., Edison B., Wildnauer, R.H. Poly acids (PHAs): clinical uses for the next of acids. Skin & Aging Sep. 2001 Supplement.



48. Yu, R.J., Van Scott, E.J. A discussion of of AHAs. Oct. 2001; 15-18.



49. Green BA, Edison BL, RH. Polyhydroxy acids (PHAs) conditioning effects to skin without to UV light. Amer Acad of Derm Poster Exhibit: New Orleans, March, 2002.



50. Green BA, Wildnauer RH. and marketing AHA products for the global market. In: Moy R, D, Kakita L, eds. acid peels. New York, NY: Marcel Dekker, 2002; pp .



51. Van Scott EJ, Yu RJ. Hydroxy acids: past, present, future. In: Moy R, Luftman D, Kakita L, eds. Glycolic acid peels. New York, NY: Marcel Dekker,2002; pp 1-14.



52. Yu RJ, Van Scott EJ. Bioavailable alpha hydroxy acid in topical formulations. In: Moy R, Luftman D, Kakita L, eds. Glycolic acid peels. New York, NY: Marcel Dekker,2002; pp 15-28.



53. Green BA, Edison BL, Lee Y. Treatment of photoaged hands. Cosmetics & Toiletries 2002;117(10):49-54.



54. Yu RJ, Van Scott EJ. Hydroxycarboxylic acids, sugars, and acids. SKINmed 2002;2: .



55. Green BA. What every esthetician should know about dry skin. Skin Inc. 2003;15(2):75-81.



56. Yu RJ, Van Scott EJ. Hydroxyacids and their use in the . In: Skin Diseases in the . Marcel Dekker, Inc. (to be in 2003).

Industry

©Copyright Consultingroom.com™ Ltd

All information contained within this site is researched and maintained for accuracy of content. Please note that for prospective purchasers of treatments, information and provided does not an in-depth with an practitioner.